Zymeworks ZYME Payments to Acquire Marketable Securities
Payments to Acquire Marketable Securities at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireMarketableSecurities.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's payments to acquire marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zymeworks's payments to acquire marketable securities?
- Zymeworks (ZYME) reported payments to acquire marketable securities of $0 in Q1 2026.
- How has Zymeworks's payments to acquire marketable securities changed year-over-year?
- Zymeworks's payments to acquire marketable securities decreased by 100.0% year-over-year, from $34.03M to $0.
- What does payments to acquire marketable securities mean?
- Cash outflows directed toward the purchase of short-term or long-term investment-grade financial instruments. This reflects the company's strategy for managing excess cash and liquidity by earning interest on idle capital.